Document Detail


Controlled cyclic stretch bioreactor for tissue-engineered heart valves.
MedLine Citation:
PMID:  19473698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A tissue-engineered heart valve (TEHV) represents the ultimate valve replacement, especially for juvenile patients given its growth potential. To date, most TEHV bioreactors have been developed based on pulsed flow of culture medium through the valve lumen to induce strain in the leaflets. Using a strategy for controlled cyclic stretching of tubular constructs reported previously, we developed a controlled cyclic stretch bioreactor for TEHVs that leads to improved tensile and compositional properties. The TEHV is mounted inside a latex tube, which is then cyclically pressurized with culture medium. The root and leaflets stretch commensurately with the latex, the stretching being dictated by the stiffer latex and thus controllable. Medium is also perfused through the lumen at a slow rate in a flow loop to provide nutrient delivery. Fibrin-based TEHVs prepared with human dermal fibroblasts were subjected to three weeks of cyclic stretching with incrementally increasing strain amplitude. The TEHV possessed the tensile stiffness and stiffness anisotropy of leaflets from sheep pulmonary valves and could withstand cyclic pulmonary pressures with similar distension as for a sheep pulmonary artery.
Authors:
Zeeshan H Syedain; Robert T Tranquillo
Related Documents :
22922618 - Doppler middle cerebral artery peak systolic velocity for diagnosis of neonatal anemia.
23449648 - Observer variability of an angiographic grading scale used for the assessment of intrac...
22938808 - Reproducibility of retinal vessel oxygen saturation measurements in healthy young subje...
12830058 - Nominal size in six bileaflet mechanical aortic valves: a comparison of orifice size an...
11128458 - Coral reef aorta: a long-term study of 21 patients.
20103228 - Factors affecting systemic oxygen delivery after norwood procedure with sano modification.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural     Date:  2009-05-26
Journal Detail:
Title:  Biomaterials     Volume:  30     ISSN:  1878-5905     ISO Abbreviation:  Biomaterials     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-07-14     Completed Date:  2009-10-06     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  England    
Other Details:
Languages:  eng     Pagination:  4078-84     Citation Subset:  IM    
Affiliation:
Department of Chemical Engineering & Materials Science, University of Minnesota, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anisotropy
Biocompatible Materials / metabolism
Bioreactors*
Cells, Cultured
Culture Media / metabolism
Extracellular Matrix / chemistry
Fibroblasts / cytology
Heart Valve Prosthesis*
Heart Valves*
Humans
Materials Testing
Sheep
Stress, Mechanical
Tensile Strength
Tissue Culture Techniques*
Tissue Engineering / instrumentation*,  methods
Grant Support
ID/Acronym/Agency:
HL71538/HL/NHLBI NIH HHS; R01 HL071538/HL/NHLBI NIH HHS; R01 HL071538-01/HL/NHLBI NIH HHS; R01 HL071538-02/HL/NHLBI NIH HHS; R01 HL071538-03/HL/NHLBI NIH HHS; R01 HL071538-04/HL/NHLBI NIH HHS; R01 HL071538-05/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biocompatible Materials; 0/Culture Media
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of UV-photofunctionalization on the time-related bioactivity of titanium and chromium-cob...
Next Document:  Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells.